drug · small molecule
patient view →PBF-999
Phase 2updated 2mo agoby Palobiofarma SL🔗 ChEMBL
Phase 2community read0 votes
Small molecule drug with a maximum clinical stage of Phase 1 (across all indications), with 2 investigational indications.
targets
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10AAdenosine receptor A2a
all catalysts(0)
nothing on the calendar yet
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that